Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01126229 · ClinicalTrials.gov registry record · Phase 1
Resveratrol for Improved Performance in the Elderly
A Phase 1 study of Memory, sponsored by University of Florida.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT01126229: Completed Phase 1 study of Memory, sponsored by University of Florida.
NCT01126229 is a Phase 1 study of Memory that has completed, run by University of Florida. The registered enrollment target is 32 participants, below the 72-participant average among 15 other Memory trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01126229, a Phase 1 study of Memory, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators aim to conduct a randomized placebo controlled pilot study to determine whether resveratrol, a dietary ingredient, supplementation is safe and improves memory and physical performance in older adults. Loss in memory and physical performance is a frequent complaint in older adults and a growing public health issue. Additionally, later adulthood is associated with a normative decline in both working and primary memory as well as domains including attention, speed of processing and executive function. Resveratrol is safely tolerated in pre-clinical models and in dose-escalation human studies. It also has demonstrated beneficial effects on memory and performance in pre-clinical models. Therefore, this study will take the next step in understanding the longer-term safety (3 months) and efficacy of resveratrol supplementation on age-related health conditions.
Primary Outcome
CBC, Complete Metabolic Panel, Toxicity according to NCI criteria
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DRUG Low dose Resveratrol
- DRUG High dose Resveratrol
Study Locations (1)
Florida
- University of Florida, Aging and Geriatric Research - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2009-11 |
| Est. Completion | 2012-12 |
| Phase | Phase 1 |
What the finished NCT01126229 record still lists
NCT01126229 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 72-participant average among 15 other Memory trials with a reported enrollment target (56% lower).
The record links to 1 condition, with Memory appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT01126229 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT01126229 about?
NCT01126229 is a clinical study titled "Resveratrol for Improved Performance in the Elderly". The investigators aim to conduct a randomized placebo controlled pilot study to determine whether resveratrol, a dietary ingredient, supplementation is safe and improves memory and physical performance in older adults. Loss in memory and physical performance is a frequent complaint in older adults a...
What is the current status of trial NCT01126229?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2009-11. Estimated completion is 2012-12.
What conditions does trial NCT01126229 study?
This clinical trial studies the following conditions: Memory.
What interventions are being tested in trial NCT01126229?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Low dose Resveratrol (DRUG), High dose Resveratrol (DRUG).
Who is sponsoring clinical trial NCT01126229?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01126229 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Memory
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01126229's enrollment target sits among peer trials
32 11th of 15 higher than 5 of 15 other Memory trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Memory trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Longitudinal Investigation of Sleep, Memory, and Brain Development Across the Nap Transition
RECRUITING · NA
-
Prediction of Anxiety and Memory State
RECRUITING · NA
-
Synchronization of Theta to Influence Memory
RECRUITING · NA
-
Home Sleep Therapy for Older Adults With MCI
RECRUITING · NA
-
Cognitive Vitality Pilot Study
RECRUITING · NA
-
Virtual Contexts for Affective Modulation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia